Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 3, 1999, Pages 295-303

  Chalon, Stephan ^a   Moreno Jr , Heitor ^a   Hoffman, Brian B ^a   Blaschke, Terrence F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM LESION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VEIN DILATATION; VENOCONSTRICTION;

EID: 0033001824     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70109-8     Document Type: Article

References (35)

1. 1. Jonas MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals. Circulation 1992;86:1664-9.
2. 2. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;30:325-33.
3. 3. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
4. 4. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34.
5. 5. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-100.
6. 6. Heitzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 1996;93:1346-53.
7. 7. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
8. 8. Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol 1995;35:679-705.
9. 9. Moreno H Jr, Chalon S, Urae A, et al. Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol 1998;275:H1040-5.
10. 10. Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelium-dependent relaxation of saphenous vein. Br J Surg 1993;80:1242-5.
11. 11. Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995;130:1270-5.
12. 12. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-H880.
13. 13. Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract-role of free radicals and attenuation by captopril. Atherosclerosis 1997;131:195-202.
14. 14. Reilly M, Delanty N, Lawson JA, Fitzgerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996;94:19-25.
15. 15. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
16. 16. Sugiyama Y, Yotsumoto H, Okabe T, Takaku F. Measurement of angiotensin-converting enzyme activity in intact human alveolar macrophages and effect of smoking. Respiration 1988;53:153-7.
17. 17. Laustiola KE, Lassila R, Nurmi AK. Enhanced activation of the renin-angiotensin-aldosterone system in chronic cigarette smokers: a study of monozygotic twin pairs discordant for smoking. Clin Pharmacol Ther 1988;44:426-30.
18. 18. Gibbons GH. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide. Clin Cardiol 1997;20(suppl II):18-25.
19. 19. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial hand veins - 1. Br J Clin Pharmacol 1994;38:181-96.
20. 20. Dachman WD, Ford GA, Blaschke TF, Hoffman BB. Mechanism of bradykinin-induced venodilation in humans. J Cardiovasc Pharmacol 1993;21:241-8.
21. 21. Donnelly R, Meredith PA, Elliott HL, Reid JL. Kinetic-dynamic relations and individual responses to enalapril. Hypertension 1990;15:301-9.
22. 22. Bohme E, Graf H, Schultz G. Effect of sodium nitroprus-side and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucl Res 1978;9:131-43.
23. 23. Vallance P, Collier J, Moncada S. Nitric oxide synthesized from L-arginine mediates endothelium-dependent dilations in human veins in vivo. Cardiovasc Res 1989;23:1053-7.
24. 24. Bedarida G, Kim D, Blaschke TF, Hoffman BB. Characterization of an inhibitor of nitric oxide synthase in human hand veins. Horm Metab Res 1994;26:109-12.
25. 25. Trap-Jensen J. Effects of smoking on the heart and peripheral circulation. Am Heart J 1988;115:258-63.
26. 26. Lekakis J, Papamichael C, Vemmos C, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997;79:529-31.
27. 27. Reinders JH, Brinkman HMJ, van Mourik JA, de Groot PG. Cigarette smoke impairs endothelial cell prostacyclin production. Arteriosclerosis 1986;6:15-23.
28. 28. Higman DJ, Strachan AMJ, Buttery L, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996;16:546-52.
29. 29. Zarnke KB, Feldman RD. Direct angiotensin converting enzyme inhibitor-mediated venodilation. Clin Pharmacol Ther 1996;59:559-68.
30. 30. Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997;95:1115-8.
31. 31. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
32. 32. Minshall RD, Tan F, Nakamura F, et al. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors: the role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells. Circ Res 1997;81:848-56.
33. 33. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996;28:1161-7.
34. 34. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.
35. 35. Harrison DG. Endothelial function and oxidant stress. Clin Cardiol 1997;20(suppl II): 11-7.